Advanced search
Publication Cover
Expert Opinion on Therapeutic Patents Volume 20, 2010 - Issue 1
Submit an article Journal homepage
583
Views
94
CrossRef citations to date
0
Altmetric
Reviews

Phospholipase A2 inhibitors as potential therapeutic agents for the treatment of inflammatory diseases

Victoria Magrioti University of Athens, Department of Chemistry, Panepistimiopolis, Athens 15771, Greece +30 210 7274462;+30 210 7274761;[email protected]
, PhD &
George Kokotos University of Athens, Department of Chemistry, Panepistimiopolis, Athens 15771, Greece +30 210 7274462;+30 210 7274761;[email protected]
, PhD
Pages 1-18 | Published online: 20 Dec 2009

Citations (94)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Jiangyong Gu, Li Li, Dongmei Wang, Wei Zhu, Ling Han, Ruizhi Zhao, Xiaojie Xu & Chuanjian Lu. (2018) Deciphering metabonomics biomarkers-targets interactions for psoriasis vulgaris by network pharmacology. Annals of Medicine 50:4, pages 323-332.
Read now
Maroula G. Kokotou, Dimitris Limnios, Aikaterini Nikolaou, Anastasia Psarra & George Kokotos. (2017) Inhibitors of phospholipase A2 and their therapeutic potential: an update on patents (2012-2016). Expert Opinion on Therapeutic Patents 27:2, pages 217-225.
Read now
Sathishkumar Chinnasamy, Selvakkumar Chinnasamy & Karthikeyan Muthusamy. (2016) High-affinity selective inhibitor against phospholipase A2 (PLA2): a computational study. Journal of Receptors and Signal Transduction 36:2, pages 111-118.
Read now
Victoria Magrioti & George Kokotos. (2013) Phospholipase A2 inhibitors for the treatment of inflammatory diseases: a patent review (2010 – present). Expert Opinion on Therapeutic Patents 23:3, pages 333-344.
Read now

Articles from other publishers (90)

Thouraya Salah, Ali Ben Ahmed, Najah Krayem, Ahlem Guesmi, Naoufel Ben Hamadi, Lotfi Khezami, Houcine Naïli & Besma Hamdi. (2024) Two different coordination polyhedra in the crystal structure of a novel Zn(II) hybrid complex: DFT investigation, biological activities and emission properties. Journal of Molecular Structure 1296, pages 136863.
Crossref
Amritlal Mandal, Mathews Valuparampil Varghese & Joel James. 2023. Phospholipases in Physiology and Pathology. Phospholipases in Physiology and Pathology 331 341 .
Devadasan Velmurugan, Anantha Krishnan Dhanabalan & Atanu Bhattacharjee. 2023. Phospholipases in Physiology and Pathology. Phospholipases in Physiology and Pathology 237 269 .
Majid Dadmehr, Bahareh Sadat Yousefsani & Jalal Pourahmad. 2023. Phospholipases in Physiology and Pathology. Phospholipases in Physiology and Pathology 55 66 .
K.J. Spandana & N. Bhagya. 2023. Phospholipases in Physiology and Pathology. Phospholipases in Physiology and Pathology 221 227 .
Kamatam Swetha, Mylanayakanahosahalli Chandrashekar Indumathi, Shiva Siddappa & Gopal Kedihithlu Marathe. 2023. Phospholipases in Physiology and Pathology. Phospholipases in Physiology and Pathology 173 189 .
Seong-Hwan Ko, Hyeon-Muk Oh, Do-Young Kwon, Jae-Eun Yang, Byung-Jun Kim, Hyun-Ju Ha, Eun-Jin Lim, Min-Seok Oh, Chang-Gue Son & Eun-Jung Lee. (2022) Incidence Rate of Bee Venom Acupuncture Related Anaphylaxis: A Systematic Review. Toxins 14:4, pages 238.
Crossref
Yao Gao, Teng Xu, Ying-Xia Zhao, Ting Ling-Hu, Shao-Bo Liu, Jun-Sheng Tian & Xue-Mei Qin. (2020) A Novel Network Pharmacology Strategy to Decode Metabolic Biomarkers and Targets Interactions for Depression. Frontiers in Psychiatry 11.
Crossref
Hamideh Kouhpeikar, Zahra Delbari, Thozhukat Sathyapalan, Luis E. Simental-Mendía, Tannaz Jamialahmadi & Amirhossein Sahebkar. (2020) The Effect of Statins through Mast Cells in the Pathophysiology of Atherosclerosis: a Review. Current Atherosclerosis Reports 22:5.
Crossref
Dongmei Wang, Chuanjian Lu, Jingjie Yu, Miaomiao Zhang, Wei Zhu & Jiangyong Gu. (2020) Chinese Medicine for Psoriasis Vulgaris Based on Syndrome Pattern: A Network Pharmacological Study. Evidence-Based Complementary and Alternative Medicine 2020, pages 1-16.
Crossref
Jun Gao, Yongxiang Zhu, Zhenglong Guo, Gangchun Xu & Pao Xu. (2020) Transcriptomic analysis reveals different responses to ammonia stress and subsequent recovery between Coilia nasus larvae and juveniles. Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology 230, pages 108710.
Crossref
A. J. Feuerherm, E. A. Dennis & B. Johansen. (2019) Cytosolic group IVA phospholipase A2 inhibitors, AVX001 and AVX002, ameliorate collagen-induced arthritis. Arthritis Research & Therapy 21:1.
Crossref
Aikaterini Nikolaou, Maroula G. Kokotou, Sofia Vasilakaki & George Kokotos. (2019) Small-molecule inhibitors as potential therapeutics and as tools to understand the role of phospholipases A2. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1864:6, pages 941-956.
Crossref
V.S. Thibane, A.R. Ndhlala, J.F. Finnie & J. Van Staden. (2019) Modulation of the enzyme activity of secretory phospholipase A2, lipoxygenase and cyclooxygenase involved in inflammation and disease by extracts from some medicinal plants used for skincare and beauty. South African Journal of Botany 120, pages 198-203.
Crossref
Octavio A. Gonzalez, Vanessa Euzebio-Alves, Yelena Alimova, Ahmad Al-Attar & J. L. Ebersole. 2019. Oral Mucosal Immunity and Microbiome. Oral Mucosal Immunity and Microbiome 79 95 .
Yong Yang, Wen‑Fa Wang, Yan‑Hua Li, Li‑Sha Li, Xin Guo & Rui Liu. (2018) Sevoflurane attenuates ventilator‑induced lung injury by regulating c‑PLA2 expression. Molecular Medicine Reports.
Crossref
Mohsen Ebrahimi, Omidreza Firuzi, Ramin Miri, Nima Razzaghi-Asl & Ahmad Ebadi. (2016) Structural Insight into Binding Mode of 9-Hydroxy Aristolochic Acid, Diclofenac and Indomethacin to PLA2. Interdisciplinary Sciences: Computational Life Sciences 10:2, pages 400-410.
Crossref
Alessandra Bragonzi, Hamed Horati, Lauren Kerrigan, Nicola Ivan Lorè, Bob J. Scholte & Sinéad Weldon. (2018) Inflammation and host-pathogen interaction: Cause and consequence in cystic fibrosis lung disease. Journal of Cystic Fibrosis 17:2, pages S40-S45.
Crossref
Irma Eloisa Monroy-Muñoz, Javier Angeles-Martinez, Rosalinda Posadas-Sánchez, Teresa Villarreal-Molina, Edith Alvarez-León, Carmina Flores-Dominguez, Guillermo Cardoso-Saldaña, Aida Medina-Urrutia, Juan Gabriel Juárez-Rojas, Carlos Posadas-Romero & Gilberto Vargas Alarcon. (2017) PLA2G2A polymorphisms are associated with metabolic syndrome and type 2 diabetes mellitus. Results from the genetics of atherosclerotic disease Mexican study. Immunobiology 222:10, pages 967-972.
Crossref
Shiyu Shu, Yan Xu, Ling Xie & Yufang Ouyang. (2017) The role of C/EBPβ phosphorylation in modulating membrane phospholipids repairing in LPS-induced human lung/bronchial epithelial cells. Gene 629, pages 76-85.
Crossref
Anneta Smyrniotou, Maroula G. Kokotou, Varnavas D. Mouchlis, Efrosini Barbayianni, George Kokotos, Edward A. Dennis & Violetta Constantinou-Kokotou. (2017) 2-Oxoamides based on dipeptides as selective calcium-independent phospholipase A 2 inhibitors. Bioorganic & Medicinal Chemistry 25:3, pages 926-940.
Crossref
Subodh K. Yadav, Sanjeev K. Sharma, Abdullah Farooque, Gaurav Kaushik, Balwinder Kaur, Chander M. Pathak, Bilikere S. Dwarakanath & Krishan L. Khanduja. (2016) Cytosolic phospholipase A2 (cPLA2) IVA as a potential signature molecule in cigarette smoke condensate induced pathologies in alveolar epithelial lineages. Lipids in Health and Disease 15:1.
Crossref
Jason W. Ashley, William D. Hancock, Alexander J. Nelson, Robert N. Bone, Hubert M. Tse, Mary Wohltmann, John Turk & Sasanka Ramanadham. (2016) Polarization of Macrophages toward M2 Phenotype Is Favored by Reduction in iPLA2β (Group VIA Phospholipase A2). Journal of Biological Chemistry 291:44, pages 23268-23281.
Crossref
Georgia Antonopoulou, Victoria Magrioti, Maroula G. Kokotou, Aikaterini Nikolaou, Efrosini Barbayianni, Varnavas D. Mouchlis, Edward A. Dennis & George Kokotos. (2016) 2-Oxoamide inhibitors of cytosolic group IVA phospholipase A2 with reduced lipophilicity. Bioorganic & Medicinal Chemistry 24:19, pages 4544-4554.
Crossref
Bogeon Yun, HeeJung Lee, Heather Ewing, Michael H. Gelb & Christina C. Leslie. (2016) Off-target effect of the cPLA2α inhibitor pyrrophenone: Inhibition of calcium release from the endoplasmic reticulum. Biochemical and Biophysical Research Communications 479:1, pages 61-66.
Crossref
Maja Nešić, Iva Popović, Andreja Leskovac & Marijana Petković. (2016) Biological activity and binding properties of [Ru(II)(dcbpy)2Cl2] complex to bovine serum albumin, phospholipase A2 and glutathione. BioMetals 29:5, pages 921-933.
Crossref
Michael S. Lustgarten, Lori L. Price, Edward M. Phillips, Dylan R. Kirn, John Mills & Roger A. Fielding. (2016) Serum Predictors of Percent Lean Mass in Young Adults. Journal of Strength and Conditioning Research 30:8, pages 2194-2201.
Crossref
Hui Wang, Michael G. Klein, Gyorgy Snell, Weston Lane, Hua Zou, Irena Levin, Ke Li & Bi-Ching Sang. (2016) Structure of Human GIVD Cytosolic Phospholipase A2 Reveals Insights into Substrate Recognition. Journal of Molecular Biology 428:13, pages 2769-2779.
Crossref
Jiung-Pang Huang, Mei-Ling Cheng, Chao-Hung Wang, Ming-Shi Shiao, Jan-Kan Chen & Li-Man Hung. (2016) High-fructose and high-fat feeding correspondingly lead to the development of lysoPC-associated apoptotic cardiomyopathy and adrenergic signaling-related cardiac hypertrophy. International Journal of Cardiology 215, pages 65-76.
Crossref
Sofia Vasilakaki, Efrosini Barbayianni, Georgios Leonis, Manthos G. Papadopoulos, Thomas Mavromoustakos, Michael H. Gelb & George Kokotos. (2016) Development of a potent 2-oxoamide inhibitor of secreted phospholipase A2 guided by molecular docking calculations and molecular dynamics simulations. Bioorganic & Medicinal Chemistry 24:8, pages 1683-1695.
Crossref
Hongjia Zhang, Rongsheng Tong, Lan Bai, Jianyou Shi & Liang Ouyang. (2016) Emerging targets and new small molecule therapies in Parkinson’s disease treatment. Bioorganic & Medicinal Chemistry 24:7, pages 1419-1430.
Crossref
Mushfiquddin Khan, Anandakumar Shunmugavel, Tajinder S Dhammu, Fumiyo Matsuda, Avtar K Singh & Inderjit Singh. (2015) Oral administration of cytosolic PLA2 inhibitor arachidonyl trifluoromethyl ketone ameliorates cauda equina compression injury in rats. Journal of Neuroinflammation 12:1.
Crossref
Michelle M. MitchenerDaniel J. HermansonErin M. ShockleyH. Alex BrownCraig W. LindsleyJeff ReeseCarol A. RouzerCarlos F. LopezLawrence J. Marnett. (2015) Competition and allostery govern substrate selectivity of cyclooxygenase-2. Proceedings of the National Academy of Sciences 112:40, pages 12366-12371.
Crossref
Sasanka Ramanadham, Tomader Ali, Jason W. Ashley, Robert N. Bone, William D. Hancock & Xiaoyong Lei. (2015) Calcium-independent phospholipases A2 and their roles in biological processes and diseases. Journal of Lipid Research 56:9, pages 1643-1668.
Crossref
Wei-Yi Ong, Tahira Farooqui, George Kokotos & Akhlaq A. Farooqui. (2015) Synthetic and Natural Inhibitors of Phospholipases A 2 : Their Importance for Understanding and Treatment of Neurological Disorders . ACS Chemical Neuroscience 6:6, pages 814-831.
Crossref
QI HUANG, YUAN WU, CHAO QIN, WENWU HE & XING WEI. (2015) Phylogenetic and structural analysis of the phospholipase A2 gene family in vertebrates. International Journal of Molecular Medicine 35:3, pages 587-596.
Crossref
Michael Rabe, Seyed R. Tabaei, Henrik Zetterberg, Vladimir P. Zhdanov & Fredrik Höök. (2014) Hydrolysis of a Lipid Membrane by Single Enzyme Molecules: Accurate Determination of Kinetic Parameters. Angewandte Chemie International Edition 54:3, pages 1022-1026.
Crossref
Michael Rabe, Seyed R. Tabaei, Henrik Zetterberg, Vladimir P. Zhdanov & Fredrik Höök. (2014) Hydrolysis of a Lipid Membrane by Single Enzyme Molecules: Accurate Determination of Kinetic Parameters. Angewandte Chemie 127:3, pages 1036-1040.
Crossref
Arjun Ram, Ulaganathan Mabalirajan, Ashish Jaiswal, Rakhshinda Rehman, Vijay Pal Singh & Balaram Ghosh. (2015) Parabromophenacyl Bromide Inhibits Subepithelial Fibrosis by Reducing TGF-β<sub>1</sub> in a Chronic Mouse Model of Allergic Asthma. International Archives of Allergy and Immunology 167:2, pages 110-118.
Crossref
George Kokotos, Astrid J. Feuerherm, Efrosini Barbayianni, Ishita Shah, Mari Sæther, Victoria Magrioti, Thuy Nguyen, Violetta Constantinou-Kokotou, Edward A. Dennis & Berit Johansen. (2014) Inhibition of Group IVA Cytosolic Phospholipase A 2 by Thiazolyl Ketones in Vitro, ex Vivo, and in Vivo . Journal of Medicinal Chemistry 57:18, pages 7523-7535.
Crossref
Toshiyuki Tomoo, Takashi Nakatsuka, Toyoko Katayama, Yasuhiro Hayashi, Yusuke Fujieda, Maki Terakawa & Kazuhiro Nagahira. (2014) Design, Synthesis, and Biological Evaluation of 3-(1-Aryl-1 H -indol-5-yl)propanoic Acids as New Indole-Based Cytosolic Phospholipase A 2 α Inhibitors . Journal of Medicinal Chemistry 57:17, pages 7244-7262.
Crossref
Shunchen Qiu, Fangjin Chen, Ying Liu & Luhua Lai. (2014) Discovery of Novel Secretory Phospholipase A 2 Inhibitors Using Virtual Screen . Chemical Biology & Drug Design 84:2, pages 216-222.
Crossref
Sarah A. Scott, Thomas P. Mathews, Pavlina T. Ivanova, Craig W. Lindsley & H. Alex Brown. (2014) Chemical modulation of glycerolipid signaling and metabolic pathways. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1841:8, pages 1060-1084.
Crossref
Xiang-Lin Yang, Yuan Zhou & Xin-Ling Liu. (2013) Hologram quantative structure–activity relationship studies on 1-(5-carboxyindol-1-yl)propan-2-one inhibitors of human cytosolic phospholipase A2α. Medicinal Chemistry Research 23:3, pages 1512-1518.
Crossref
Marcel Schumann & Roger S. Armen. (2013) Identification of Distant Drug Off-Targets by Direct Superposition of Binding Pocket Surfaces. PLoS ONE 8:12, pages e83533.
Crossref
Jong Min Choi, Young Hwa Choi, Seok Kyun Kim, Kyong Hoon Ahn, Jong Hoon Won, Joo Hyuk Lim, You Jin Jang, Sungsook Lee, Dal-Hyun Kim & Dae Kyong Kim. (2013) (S)-tetrahydroisoquinoline alkaloid inhibits LPS-induced arachidonic acid release through downregulation of cPLA2 expression. Molecules and Cells 36:5, pages 400-409.
Crossref
Tina Kamčeva, Maja Radisavljević, Iva Vukićević, Jürgen Arnhold & Marijana Petković. (2013) Interactions of Platinum and Ruthenium Coordination Complexes with Pancreatic Phospholipase A 2 and Phospholipids Investigated by MALDI TOF Mass Spectrometry . Chemistry & Biodiversity 10:11, pages 1972-1986.
Crossref
Ana Zaragoza, José A. Teruel, Francisco J. Aranda & Antonio Ortiz. (2013) Interaction of a trehalose lipid biosurfactant produced by Rhodococcus erythropolis 51T7 with a secretory phospholipase A2. Journal of Colloid and Interface Science 408, pages 132-137.
Crossref
Seyed R. Tabaei, Michael Rabe, Henrik Zetterberg, Vladimir P. Zhdanov & Fredrik Höök. (2013) Single Lipid Vesicle Assay for Characterizing Single-Enzyme Kinetics of Phospholipid Hydrolysis in a Complex Biological Fluid. Journal of the American Chemical Society 135:38, pages 14151-14158.
Crossref
Victoria Magrioti, Aikaterini Nikolaou, Annetta Smyrniotou, Ishita Shah, Violetta Constantinou-Kokotou, Edward A. Dennis & George Kokotos. (2013) New potent and selective polyfluoroalkyl ketone inhibitors of GVIA calcium-independent phospholipase A2. Bioorganic & Medicinal Chemistry 21:18, pages 5823-5829.
Crossref
Paul D. Robinson & Peter Van Asperen. (2013) Newer Treatments in the Management of Pediatric Asthma. Pediatric Drugs 15:4, pages 291-302.
Crossref
Shailesh V. Jain, Manjunath Ghate, Kamlendra S. Bhadoriya, Sanjaykumar B. Bari, Gopal Sugandhi & Prashant Mandwal. (2012) 3D-QSAR pharmacophore modeling and in silico screening of phospholipase A2α inhibitors. Medicinal Chemistry Research 22:7, pages 3096-3108.
Crossref
Yuan-Hao Hsu, Denis Bucher, Jian Cao, Sheng Li, Sheng-Wei Yang, George Kokotos, Virgil L. WoodsJrJr, J. Andrew McCammon & Edward A. Dennis. (2013) Fluoroketone Inhibition of Ca 2+ -Independent Phospholipase A 2 through Binding Pocket Association Defined by Hydrogen/Deuterium Exchange and Molecular Dynamics . Journal of the American Chemical Society 135:4, pages 1330-1337.
Crossref
Woo Seok Yang, Deok Jeong, Young-Su Yi, Jae Gwang Park, Hyohyun Seo, Sang Hyun Moh, Sungyoul Hong & Jae Youl Cho. (2013) IRAK1/4-Targeted Anti-Inflammatory Action of Caffeic Acid. Mediators of Inflammation 2013, pages 1-12.
Crossref
Jian Cao, John E. Burke & Edward A. Dennis. (2013) Using Hydrogen/Deuterium Exchange Mass Spectrometry to Define the Specific Interactions of the Phospholipase A2 Superfamily with Lipid Substrates, Inhibitors, and Membranes. Journal of Biological Chemistry 288:3, pages 1806-1813.
Crossref
Ioanna Sevastou, Eleanna Kaffe, Marios-Angelos Mouratis & Vassilis Aidinis. (2013) Lysoglycerophospholipids in chronic inflammatory disorders: The PLA2/LPC and ATX/LPA axes. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1831:1, pages 42-60.
Crossref
Vladimir A. Tyurin, Naveena Yanamala, Yulia Y. Tyurina, Judith Klein-Seetharaman, Colin H. Macphee & Valerian E. Kagan. (2012) Specificity of Lipoprotein-Associated Phospholipase A 2 toward Oxidized Phosphatidylserines: Liquid Chromatography–Electrospray Ionization Mass Spectrometry Characterization of Products and Computer Modeling of Interactions . Biochemistry 51:48, pages 9736-9750.
Crossref
Tomohiko Makiyama, Hiroyuki Nakamura, Atsushi Nishida & Toshihiko Murayama. (2012) C2-di-ethyl-ceramide-1-phosphate as an inhibitor of group IVA cytosolic phospholipase A2. European Journal of Pharmacology 697:1-3, pages 144-151.
Crossref
Rob C. Oslund & Michael H. Gelb. (2012) Biochemical Characterization of Selective Inhibitors of Human Group IIA Secreted Phospholipase A 2 and Hyaluronic Acid-Linked Inhibitor Conjugates . Biochemistry 51:43, pages 8617-8626.
Crossref
MATTHIAS LEHR. 2012. Anti-Inflammatory Drug Discovery. Anti-Inflammatory Drug Discovery 35 57 .
Walburga Hanekamp & Matthias Lehr. (2012) Determination of arachidonic acid by on-line solid-phase extraction HPLC with UV detection for screening of cytosolic phospholipase A2α inhibitors. Journal of Chromatography B 900, pages 79-84.
Crossref
David Y. Hui. (2012) Phospholipase A2 enzymes in metabolic and cardiovascular diseases. Current Opinion in Lipidology 23:3, pages 235-240.
Crossref
Efrosini Barbayianni, Georgia Antonopoulou & George Kokotos. (2012) Potent and selective 2-oxoamide inhibitors of phospholipases A2 as novel medicinal agents for the treatment of inflammatory diseases. Pure and Applied Chemistry 84:9, pages 1877-1894.
Crossref
Jinyong Choi, Seon-Hee Kim & Sunyoung Kim. (2012) Suppressive effects of PG201, an antiarthritic botanical formulation, on lipopolysaccharide-induced inflammatory mediators in Raw264.7 cells. Experimental Biology and Medicine 237:5, pages 499-508.
Crossref
Piotr Gałecki, Elżbieta Gałecka, Michael Maes, Marcelina Chamielec, Agata Orzechowska, Kinga Bobińska, Andrzej Lewiński & Janusz Szemraj. (2012) The expression of genes encoding for COX-2, MPO, iNOS, and sPLA2-IIA in patients with recurrent depressive disorder. Journal of Affective Disorders 138:3, pages 360-366.
Crossref
Ki‐Seok Choi, Eun‐Hee Kim, Hua Hong, Chan Young Ock, Jeong Sang Lee, Joo‐Hyun Kim & Ki‐Baik Hahm. (2012) Attenuation of cysteamine‐induced duodenal ulcer with Cochinchina momordica seed extract through inhibiting cytoplasmic phospholipase A 2 /5‐lipoxygenase and activating γ‐glutamylcysteine synthetase . Journal of Gastroenterology and Hepatology 27:s3, pages 13-22.
Crossref
Elisângela Aparecida Aragão, Davi Serradella Vieira, Lucimara Chioato, Tatiana Lopes Ferreira, Marcos Roberto Lourenzoni, Samuel Reghim Silva & Richard John Ward. (2012) Characterization of suramin binding sites on the human group IIA secreted phospholipase A2 by site-directed mutagenesis and molecular dynamics simulation. Archives of Biochemistry and Biophysics 519:1, pages 17-22.
Crossref
K. Roebrock, M. Wolf, S. Bovens, M. Lehr & C. Sunderkötter. (2012) Inhibition of benzalkonium chloride-induced skin inflammation in mice by an indol-1-ylpropan-2-one inhibitor of cytosolic phospholipase A2α. British Journal of Dermatology 166:2, pages 306-316.
Crossref
Denis Blache, Thomas Gautier, Uwe J. F. Tietge & Laurent Lagrost. (2011) Activated platelets contribute to oxidized low‐density lipoproteins and dysfunctional high‐density lipoproteins through a phospholipase A2‐dependent mechanism. The FASEB Journal 26:2, pages 927-937.
Crossref
Varnavas D. Mouchlis, Vasiliki Michopoulou, Violetta Constantinou-Kokotou, Thomas Mavromoustakos, Edward A. Dennis & George Kokotos. (2012) Binding Conformation of 2-Oxoamide Inhibitors to Group IVA Cytosolic Phospholipase A 2 Determined by Molecular Docking Combined with Molecular Dynamics . Journal of Chemical Information and Modeling 52:1, pages 243-254.
Crossref
Peter J. Barnes. (2012) Severe asthma: Advances in current management and future therapy. Journal of Allergy and Clinical Immunology 129:1, pages 48-59.
Crossref
Stefan M. Noha, Bianca Jazzar, Susanne Kuehnl, Judith M. Rollinger, Hermann Stuppner, Anja M. Schaible, Oliver Werz, Gerhard Wolber & Daniela Schuster. (2012) Pharmacophore-based discovery of a novel cytosolic phospholipase A2α inhibitor. Bioorganic & Medicinal Chemistry Letters 22:2, pages 1202-1207.
Crossref
Edward A. Dennis, Jian Cao, Yuan-Hao Hsu, Victoria Magrioti & George Kokotos. (2011) Phospholipase A 2 Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention . Chemical Reviews 111:10, pages 6130-6185.
Crossref
Daniele De Luca, Angelo Minucci, Domenico Tripodi, Marco Piastra, Domenico Pietrini, Cecilia Zuppi, Giorgio Conti, Virgilio P. Carnielli & Ettore Capoluongo. (2011) Role of distinct phospholipases A2 and their modulators in meconium aspiration syndrome in human neonates. Intensive Care Medicine 37:7, pages 1158-1165.
Crossref
Cécile Fèvre, Sandrine Bellenger, Anne-Sophie Pierre, Mélaine Minville, Jérôme Bellenger, Joseph Gresti, Mickaël Rialland, Michel Narce & Christian Tessier. (2011) The metabolic cascade leading to eicosanoid precursors – desaturases, elongases, and phospholipases A2 – is altered in Zucker fatty rats. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1811:6, pages 409-417.
Crossref
Jeffrey M CraftDennis Hallahan. (2011) Towards novel radiosensitizing agents: the role of cytosolic PLA2α in combined modality cancer therapy. Future Medicinal Chemistry 3:7, pages 835-843.
Crossref
Diana Gaspar, Marlene Lúcio, Sandra Rocha, J.L.F. Costa Lima & Salette Reis. (2011) Changes in PLA2 activity after interacting with anti-inflammatory drugs and model membranes: evidence for the involvement of tryptophan residues. Chemistry and Physics of Lipids 164:4, pages 292-299.
Crossref
Stefan Zahov, Andreas Drews, Mark Hess, Alwine Schulze Elfringhoff & Matthias Lehr. (2011) 1‐(3‐Biaryloxy‐2‐oxopropyl)indole‐5‐carboxylic Acids and Related Compounds as Dual Inhibitors of Human Cytosolic Phospholipase A 2 α and Fatty Acid Amide Hydrolase . ChemMedChem 6:3, pages 544-549.
Crossref
Martina Kaptur, Alwine Schulze Elfringhoff & Matthias Lehr. (2011) Structure–activity relationship studies on 1-(5-carboxyindol-1-yl)-propan-2-one inhibitors of human cytosolic phospholipase A2α: Variation of the activated ketone moiety. Bioorganic & Medicinal Chemistry Letters 21:6, pages 1773-1776.
Crossref
Young Man Lee. (2011) A Study on the Mechanism of Immunomodulating Effects of Moxifloxacin in Oleic Acid-Induced Acute Lung Injury. Tuberculosis and Respiratory Diseases 71:2, pages 97.
Crossref
Hitoshi NakayamaYuka Morita, Hirohiko KimuraKeiichi Ishihara, Satoshi Akiba & Jun'ichi Uenishi. (2011) Synthesis of N-(Trifluoromethyl-2-pyridinyl)arenesulfonamides as an Inhibitor of Secretory Phospholipase A2. Chemical and Pharmaceutical Bulletin 59:6, pages 783-786.
Crossref
Varnavas D. Mouchlis, Victoria Magrioti, Efrosini Barbayianni, Nathan Cermak, Rob C. Oslund, Thomas M. Mavromoustakos, Michael H. Gelb & George Kokotos. (2011) Inhibition of secreted phospholipases A2 by 2-oxoamides based on α-amino acids: Synthesis, in vitro evaluation and molecular docking calculations. Bioorganic & Medicinal Chemistry 19:2, pages 735-743.
Crossref
Shivaprasad H. Venkatesha, Brian M. Berman & Kamal D. Moudgil. (2011) Herbal medicinal products target defined biochemical and molecular mediators of inflammatory autoimmune arthritis. Bioorganic & Medicinal Chemistry 19:1, pages 21-29.
Crossref
Stefanie Bovens, Alwine Schulze Elfringhoff, Martina Kaptur, Dirk Reinhardt, Michael Schäfers & Matthias Lehr. (2010) 1-(5-Carboxyindol-1-yl)propan-2-one Inhibitors of Human Cytosolic Phospholipase A 2 α: Effect of Substituents in Position 3 of the Indole Scaffold on Inhibitory Potency, Metabolic Stability, Solubility, and Bioavailability . Journal of Medicinal Chemistry 53:23, pages 8298-8308.
Crossref
Varnavas D. Mouchlis, Thomas M. Mavromoustakos & George Kokotos. (2010) Molecular Docking and 3D-QSAR CoMFA Studies on Indole Inhibitors of GIIA Secreted Phospholipase A 2 . Journal of Chemical Information and Modeling 50:9, pages 1589-1601.
Crossref
Andreas Drews, Stefanie Bovens, Kirsten Roebrock, Cord Sunderkötter, Dirk Reinhardt, Michael Schäfers, Andrea van der Velde, Alwine Schulze Elfringhoff, Jörg Fabian & Matthias Lehr. (2010) 1-(5-Carboxyindol-1-yl)propan-2-one Inhibitors of Human Cytosolic Phospholipase A 2 α with Reduced Lipophilicity: Synthesis, Biological Activity, Metabolic Stability, Solubility, Bioavailability, And Topical in Vivo Activity . Journal of Medicinal Chemistry 53:14, pages 5165-5178.
Crossref
Peter J. Barnes. (2010) New therapies for asthma: is there any progress?. Trends in Pharmacological Sciences 31:7, pages 335-343.
Crossref
Jinmei Wang & Miriam Kolko. (2010) Phospholipases A2 in ocular homeostasis and diseases. Biochimie 92:6, pages 611-619.
Crossref
Varnavas D. Mouchlis, Thomas M. Mavromoustakos & George Kokotos. (2010) Design of new secreted phospholipase A2 inhibitors based on docking calculations by modifying the pharmacophore segments of the FPL67047XX inhibitor. Journal of Computer-Aided Molecular Design 24:2, pages 107-115.
Crossref
Young Man Lee. (2010) Moxifloxacin Alleviates Oleic Acid-provoked Neutrophilic Respiratory Burst in the Rat Lung through the Inhibition of Cytosolic Phospholipase A 2 . Tuberculosis and Respiratory Diseases 69:4, pages 256.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.